Date: September 17, 2024
Broker: CGS-CIMB Securities

Company Overview

Sino Biopharmaceutical Ltd (Stock Code: 1177) is a major pharmaceutical company based in Hong Kong. It focuses on the research, development, production, and distribution of biopharmaceutical products. The company is a significant player in the healthcare and pharmaceutical sectors in Asia.

Stock Recommendation: Technical Buy

Sino Biopharmaceutical Ltd is currently rated as a Technical Buy. The stock has multiple entry levels, offering an attractive opportunity for investors interested in the healthcare sector.

Entry and Stop Loss Levels

• Entry Prices: The recommended entry prices are 3.27, 3.03, and 2.72 HKD.
• Stop Loss: The stop-loss level is set at 2.57 HKD, providing protection in case of downward price movements.

Target Prices

The stock has a range of target prices, suggesting significant upside potential:

• Target 1: 3.68 HKD
• Target 2: 4.04 HKD
• Target 3: 4.50 HKD
• Target 4: 5.10 HKD

Investment Rationale

The technical indicators for Sino Biopharmaceutical Ltd are favorable, reflecting a strong potential for price growth. The recommended entry points and target levels offer a structured approach to benefit from this potential. Investors should monitor the stock closely and adhere to stop-loss levels to manage risk.